Table 4.
No | Histology postop | Histology preop | Typical imaging (atypical) | IgG | IgG4 | AAB | Other organ involvement | Steroid trial | Asian positivee | HISORt positive |
---|---|---|---|---|---|---|---|---|---|---|
5 | AIP type 2 | n.a. | No | n.a. | n.a. | n.a. | No | No | No | Possiblec |
7 | AIP type 1 | n.a. | No (focal mass) | n.a. | n.a. | n.a. | Hypothyroidism | No | No | Possiblec |
10 | AIP type 2 | n.a. | No | n.a. | n.a. | n.a. | No | No | No | Possiblec |
15 | AIP type 2 | n.a. | No (focal mass) | 11.8a | 1.39a | n.a. | No | No | No | Nod |
16 | AIP type 1 | n.a. | No (focal mass) | 33.0a | 13.6a | Negative | Retroperitoneal Fibrosis | No | No | Yes |
19 | AIC | n.a. | Biliary stricture | n.a. | n.a. | n.a. | No | No | No | Possiblec |
23 | AIP type2 | Malignantb | No (diffuse enlargement no rim, focal mass) | 8.6 | 0.05 | n.a. | No | No | No | Nod |
IgG normal <17.0 g/L, IgG4 nl <1.40 g/L. n.a. not available, AAB auto antibodies (RF, ANA)
aPreoperative values, measured retrospectively, b cytology (EUS FNA), c if serology positive and/or suggestive pancreatogram, responsiveness to steroids would have confirmed diagnosis, d even if responsive to steroids, diagnostic criteria would not have been met, e none of the patients had adequate (mandatory) pancreatogram; patients 16 and 19 had double duct sign on ERCP with minimal contrast injection